Encephalitis and schizophrenia: A matter of words

British Journal of Psychiatry

Volumn 201, Issue 1, 2012, Pages 74-

  O'Loughlin, Kieran ^a   Ruge, Paul ^a   McCauley, MacDara ^a  

^a Louth Mental Health Service   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

BRAIN DISEASE; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; HUMAN; ICD-10; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MEDICAL LITERATURE; NEUROIMAGING; PSYCHOSIS; SCHIZOPHRENIA;

ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; ENCEPHALITIS; FEMALE; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84863587319     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.201.1.74     Document Type: Letter

References (4)

1. Lennox BR, Coles AJ, Vincent A. Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry 2012; 200: 92-4.
2. Barry H, Hardiman O, Healy DG, Keogan M, Moroney J, Molnar PP, et al. Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry 2011; 199: 508-9.
3. Williams L, Newton G, Roberts K, Finlayson S, Brabbins C. Clozapine-resistant schizophrenia: a positive approach. Br J Psychiatry 2002; 181: 184-7. (Pubitemid 34983522)
4. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.